Amgen Inc. Equity-NMS: AMGN

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$311.55
Open :$310.58
Today's high :$312.62
Today's low :$305
52W low :$251.27
52W high :$338.9803
1Y :7.11%
5Y :47.57%
EPS(TTM): :7.55
Shares O/S :537.2 M
Market cap :164.88 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Amgen Inc. $306.92 -10.95% 40.66 164.88B

Frequently Asked Questions

What is the share price of Amgen Inc. today?

Amgen Inc. (AMGN) share price as of April 2, 2025, is $305.69. If you are investing from India, you can always check the valuation in the INR before investing.

About Amgen Inc.

Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.